Literature DB >> 19411973

Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report.

Katherine V Zamora1, John J Males.   

Abstract

PURPOSE: : To report a case of polymicrobial keratitis caused by Streptococcus salivarius, Streptococcus oralis, and coagulase-negative Staphylococcus sp. in a patient who underwent collagen cross-linking for keratoconus.
METHOD: : Case report. RESULT: : A 32-year-old male presented with a 1-day history of a painful red eye, occurring 3 days after he had undergone a collagen cross-linking with riboflavin and UV-A on his left eye for keratoconus. He admitted to removing his bandage contact lens and cleaning it in his mouth before reapplying it in his eye. On presentation, a severe keratitis with an 8-mm epithelial defect and 360-degree ring infiltrate was found. Culture results from his contact lens were positive for S. salivarius and S. oralis, and coagulase-negative Staphylococcus sp. were grown from his corneal scrapings.
CONCLUSIONS: : Collagen cross-linking is a promising procedure for the treatment of progressive keratoconus with minimal reported side effects. However, the possibility of a secondary infection after the procedure exists because the patient is subjected to epithelial debridement and the application of a soft contact lens. The role of the UV light on the immune mechanisms of the cornea and its effect on corneal wound healing warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411973     DOI: 10.1097/ICO.0b013e31818d381a

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  38 in total

1.  [Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome].

Authors:  C Faschinger; R Kleinert; A Wedrich
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

Review 2.  [Complications of corneal cross-linking].

Authors:  T G Seiler; G Schmidinger; I Fischinger; T Koller; T Seiler
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

3.  Ultrasound-enhanced penetration of topical riboflavin into the corneal stroma.

Authors:  Ricardo Lamy; Elliot Chan; Hui Zhang; Vasant A Salgaonkar; Sam D Good; Travis C Porco; Chris J Diederich; Jay M Stewart
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-28       Impact factor: 4.799

Review 4.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

5.  Ring infiltrate in staphylococcal keratitis.

Authors:  Batriti S Wallang; Sujata Das; Savitri Sharma; Srikant K Sahu; Ruchi Mittal
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

6.  Biological and biomechanical responses to traditional epithelium-off and transepithelial riboflavin-UVA CXL techniques in rabbits.

Authors:  Brian K Armstrong; Michelle P Lin; Matthew R Ford; Marcony R Santhiago; Vivek Singh; Gregory H Grossman; Vandana Agrawal; Roy A Sinha; Robert S Butler; William J Dupps; Steven E Wilson
Journal:  J Refract Surg       Date:  2013-05       Impact factor: 3.573

7.  Corneal collagen cross-linking.

Authors:  Mirko R Jankov Ii; Vesna Jovanovic; Ljubisa Nikolic; Jonathan C Lake; Georgos Kymionis; Efekan Coskunseven
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

8.  Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01

Review 9.  Pediatric keratoconus: a review of the literature.

Authors:  Sabrina Mukhtar; Balamurali K Ambati
Journal:  Int Ophthalmol       Date:  2017-08-29       Impact factor: 2.031

10.  Transepithelial accelerated corneal collagen cross-linking with higher oxygen availability for keratoconus: 1-year results.

Authors:  Ling Sun; Meng Li; Xiaoyu Zhang; Mi Tian; Tian Han; Jing Zhao; Xingtao Zhou
Journal:  Int Ophthalmol       Date:  2017-11-07       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.